FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/100377 [Registered on: 06/01/2026] Trial Registered Prospectively
Last Modified On: 31/12/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia
Preventive 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   To study effect of spraying medicine in patients throat during general anesthesia on the occurrence of post operative sore throat  
Scientific Title of Study   Effect of intratracheal dexmedetomidine combined with ropivacaine on postoperative sore throat:A prospective randomised controlled study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Janet KJ 
Designation  Post graduate student  
Affiliation  St Johns Medical College and Hospital  
Address  2 nd floor operation theatre complex, Department of anesthesia and critical care,St Johns Medical College Hospital,Banglore, Karnataka

Bangalore
KARNATAKA
560034
India 
Phone  9447580431  
Fax    
Email  janetkjan@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Surbhi Gupta 
Designation  Professor  
Affiliation  St Johns Medical College and Hospital  
Address  2 nd floor operation theatre complex, Department of anesthesia and critical care,St Johns Medical College Hospital,Banglore, Karnataka

Bangalore
KARNATAKA
560034
India 
Phone  9880109361  
Fax    
Email  surbhi_pg@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Surbhi Gupta  
Designation  Professor  
Affiliation  St Johns Medical College and Hospital  
Address  2 nd floor operation theatre complex, Department of anesthesia and critical care,St Johns Medical College Hospital,Banglore, Karnataka

Bangalore
KARNATAKA
560034
India 
Phone  9880109361  
Fax    
Email  surbhi_pg@yahoo.com  
 
Source of Monetary or Material Support  
St Johns Medical College and Hospital, Koramangala, Bangalore 560034 
 
Primary Sponsor  
Name  Dr Janet KJ  
Address  2 nd floor operation theatre complex, Department of anesthesia and critical care,St Johns Medical College Hospital,Banglore, Karnataka  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Janet KJ   St Johns Medical College and Hospital   Department of anesthesiology,second floor OT complex,St Johns Medical College and Hospital, Koramangala, Bangalore,560034
Bangalore
KARNATAKA 
9447580431

janetkjan@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: 3||Administration, (2) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Control group   No drug will be used in this group.In these patients, before performing endo tracheal intubation throat will be sprayed with normal saline.Sore throat and hoarsness of voice will be assessed at 0,2,6,12 and 24 hours after extubation. 
Intervention  Intratracheal administration of dexmedetomidine combined with ropivacaine   In these group of patients , before performing endo tracheal intubation, combination of dexmedetomidine and ropivacaine will be sprayed.Severity of throat pain and hoarsness will be assessed after 0,2,6,12 and 24 hours after extubation  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  59.00 Year(s)
Gender  Both 
Details  ASA I and II 
 
ExclusionCriteria 
Details  BMI more than or equal to 30kg/m2
Maxillofacial and head and neck surgery and surgeries requiring throat pack
Stylet guided intubation
More than one intubation attempt
Nasogastric tube insertion
Videolaryngoscope aided intubation  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
To evaluate the effect of intratracheal installation of dexmedetomidine with ropivacaine compared with normal saline on incidence and grading of postoperative sore throat   To evaluate the effect of intratracheal installation of dexmedetomidine with ropivacaine compared with normal saline on incidence and grading of postoperative sore throat at 0,2,6, 12 and 24 hours after t 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Introduction Endotracheal intubation involves inserting a tube into the trachea to facilitate mechanical ventilation during general anaesthesia While essential this procedure can injure the airway mucosaleading to postoperative sore throat POSTa common complication with an incidence rate of up to 61 point 8 percentage 1 POST can cause significant discomfort negatively affecting patient satisfaction
To mitigate POSTvarious prophylactic methods have been explored including
Nebulised agents such as ketamine dexmedetomidine steroids and magnesium sulphate
Intravenous administration of lidocaine and dexamethasone
Topical spray with local anaesthetics2
Choosing appropriate size of the endotracheal tube
Optimal endotracheal tube cuff pressure
Replacing a double lumen tube with an endobronchial blocker
Each of these interventions has its own limitations and varying degrees of effectiveness
Ropivacainean amide local anestheticblocks voltagegated sodium channels in nerve cells inhibiting nerve impulse conductionSeveral studies have explored the use of topical local anesthetic sprays and jellies to reduce sore throat hoarsenessand tracheal irritation associated with endotracheal intubation3 Topical ropivacaine has been utilized to mitigate the hemodynamic response during intubation and extubation while also reducing the incidence of peri extubation cough
Dexmedetomidine an alpha2 adrenergic receptor agonist exerts sedative anxiolytic and analgesic effects 4 It has been used as an additive to local anesthetics to prolong analgesia and has also been administered intravenously and via preoperative nebulization to reduce the incidence of POST However limited research has investigated its intratracheal administration as a potential method to modulate the hemodynamic response to endotracheal intubation and prevent POST
Therefore we hypothesized that intratracheal administration of dexmedetomidine combined with ropivacaine could effectively reduce both the incidence and severity of POST following endotracheal intubation
Need for the study POST is a minor but distressing complication for a patient after GA Various prophylactic pharmacological and nonpharmacological measures have been studied to reduce the incidence and the severity of the same We hypothesize that the intratracheal route of administration of drugs may have lesser side effects compared to intravenous route and may be more effective as it is in direct contact with the tracheal mucosal surface As very few studies have been conducted to evaluate the use of intratracheal drugs on POST we plan to conduct this study to determine the use of Dexmedetomidine combined with Ropivacaine for prevention of POST 
Objectives of the study
Primary Objective
To evaluate the effect of intratracheal instillation of Dexmedetomidine with Ropivacaine compared with normal saline on the incidence and grading of postoperative sore throat
Secondary Objectives
1To study the incidence and grading of postoperative hoarseness of voice
1To assess haemodynamic response to endotracheal intubation by comparing the vitals heart ratesystolic diastolic and mean arterial blood pressure between the two groups at specific time points
2 To note adverse reactions if any
Materials and methods
Source Of Data St Johns National Academy Of Health SciencesBengaluru Study Period 2 Years
Study Design Randomized Controlled Trial Sample Size 30 patients Per Group
a SUBJECTS
Inclusion criteria
Patients of ASA Physical status I-II of either sex
Mallampati Grading of airway I and II
18 to 59 years of age scheduled for surgeries under General Anesthesia with oral endotracheal intubation and in supine position
Exclusion criteria
BMI more than or equal to30 kg per metre square
Maxillofacial and head and neck surgery and surgeries requiring packing the throat
Stylet guided intubation 
More than one intubation attempt
Nasogastric tube insertion 
Videolarygoscope aided intubation
Methodology
A prospective randomized double blind study will be conducted after obtaining approval from 
the Institutional Ethics Committee IECand written informed consent
60 patients between the age of 18 59 years belonging to ASA Physical Status I or II undergoing surgeries in the supine position under general anaesthesia with an oral endotracheal tube will be recruited for the study
Using a computergenerated sequence patients will be randomly allocated into two groups Details of the group assignments will be sealed in sequentially numbered opaque envelopesv One anaesthesiologist will prepare the study drug in a syringe according to group assignment Another anaesthesiologist who will be blinded to the group assignments will inject the study drug intubate the patient and record the study parameters 
Group DR Patients will receive intratracheal 075 percentage ropivacaine 4 mland dexmedetomidine 50 mcg made upto 5 ml with normal saline
Group S Patients will receive intratracheal normal saline 5 ml
All patients will be subjected to a detailed pre-anesthetic evaluation
On the day of surgery nil per oral status will be confirmed Standard American Society of Anesthesiologists ASA monitors will be attached to the patient and baseline vitals such as heart rate HR Systolic blood pressure SBP Diastolic blood pressure DBP Mean Arterial Pressure MAP and oxygen saturation SPO2 will be recorded
Intravenous access will be secured and a balanced salt solution will be started.
Patients will be first preoxygenated with 100 percent oxygen for 3 minutes. Premedication consisting of 10 mcg per kg glycopyrrolate 01mg per kg ondansetron and 001 mg per kg midazolam intravenously iv will be given Induction will be done using fentanyl 2 mcg per kg and propofol 1 2 mg per kg iv till loss of verbal response Injection atracurium 0 5mg per kg iv will be given for muscle relaxation 
After 3 minutes of injecting the relaxant direct laryngoscopy using Macintosh laryngoscope will be done and 5 ml of the study drug will be sprayed onto the glottis and into the trachea using a mucosal atomizer device for uniform surface anesthesia The patient will be ventilated for 2 minutes and then intubated with a cuffed polyvinyl chloride PVC endotracheal tube of size 7 mm in females and 8 mm in males using a MacIntosh laryngoscope All intubations will be done by an experienced Anaesthesiologist
Air entry will be checked bilaterally and tube position confirmed by end tidal CO2 ETCO2 tracing The endotracheal cuff will be inflated and maintained at a pressure of 2030 cm H2O with the help of a cuff pressure manometer Anesthesia will be maintained with oxygen air and Isoflurane and intermittent bolus doses of Atracurium Intraoperatively patients will receive routine standard of care 
At the end of surgery the neuromuscular block will be reversed with injection glycopyrrolate 10 mcg per kg and injection neostigmine 005 0 07 mg per kg iv After adequate recovery patients will be extubated 
The SBP DBP MAP SPO2 before induction T0 before surface anesthesia T1 after surface anesthesia T2 before intubation T3 after intubation T4 and 1 min after intubation T5 3mins after intubation T6 and 5 mins after intubation T7 will be noted 
Severity of sore throat and hoarseness of voice will be assessed at 0 2 6 12 and 24 hr after extubation as per the grading criteria below
Grading of Sore Throat
0No sore throat
1 Mild sore throat complained of sore throat only when asked
2Moderate sore throat selfreported sore throat
3Severe sore throat pain and discomfort in the pharynx causing hoarseness or vocal change
Grading of Hoarseness of voice
0 No hoarseness
1 Mild hoarseness complained of hoarseness only when asked
2 Moderate hoarseness selfreported hoarseness
3Severe hoarseness observable change in voice

 
Close